Clinical trial
Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study
NCT07187700 is registered in ClinicalTrials.gov with Amsterdam UMC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study
- Lead sponsor
- Amsterdam UMC
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- December 31, 2030
- Enrollment
- 1,100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal aorta aneurism, peripheral arterial disease